Medtronic has completed the first patient procedure using its Achieve Mapping Catheter, an intra-cardiac electrophysiology diagnostic catheter.
The catheter can assess pulmonary vein isolation when treating paroxysmal atrial fibrillation and provide a simpler treatment option by combining pulmonary vein diagnostic and ablation capabilities in a single system.
The Arctic Front Cardiac CryoAblation Catheter is the first cryoballoon used for the treatment of paroxysmal atrial fibrillation involving a minimally-invasive method that creates circumferential lesions around the pulmonary vein and blocks the conduction of atrial fibrillation in cardiac tissue through the use of a coolant.
The Achieve Mapping Catheter, which has received US Food and Drug Administration approval, is set up with the Arctic Front guide wire lumen, enabling the Arctic Front procedure to be performed by a single transseptal puncture with minimal catheter exchanges.
Medtronic Atrial Fibrillation Solutions Division vice-president and general manager Reggie Groves said the catheter enables physicians to engage in real-time evaluation of pulmonary vein isolation.